ModerateSynergy
B9 (folate) and B12 work together in the methionine cycle. B12 deficiency can be masked by high folate intake.
Recommendation: Always supplement B12 when taking folate. B12 deficiency with high folate can cause irreversible neurological damage if undetected.
InfoCaution
High-dose zinc (>40mg) may impair folate absorption by inhibiting the folate conjugase enzyme in the gut.
Recommendation: If taking high-dose zinc, monitor folate status or separate doses.
InfoSynergy
Vitamin C protects folate from oxidative degradation and helps maintain it in its reduced, active form.
Recommendation: Take together. Vitamin C preserves folate stability in the blood and tissues.
InfoSynergy
B6 is required for the conversion of serine to glycine, which generates 5,10-methyleneTHF needed for folate-dependent one-carbon metabolism.
Recommendation: Take as part of a B-complex for optimal one-carbon metabolism and homocysteine management.
SeriousContraindicated
Methotrexate (Cancer)
Folate can interfere with methotrexate's anticancer mechanism. Note: folate supplementation IS beneficial with low-dose MTX for rheumatoid arthritis.
Recommendation: Cancer patients on MTX should NOT take folate without oncologist approval.
InfoSynergy
Methylfolate is the methyl donor that enables homocysteine remethylation to methionine via methionine synthase.
Recommendation: Always pair methionine with adequate methylfolate (and B12) to manage homocysteine.
InfoSynergy
Both contribute to the methyl donor pool; choline can compensate for low folate in some methylation reactions and vice versa.
Recommendation: Pairing supports overall methylation status, particularly in homocysteine elevation. Useful when MTHFR variants reduce folate-mediated methylation.
InfoSynergy
Riboflavin is the cofactor for the MTHFR enzyme that converts folate to its active form, so good riboflavin status improves folate-mediated lowering of homocysteine, especially in people with the MTHFR 677 TT genotype.
Recommendation: Ensure adequate riboflavin when using methylfolate to lower homocysteine, particularly for MTHFR 677 TT individuals in whom riboflavin status strongly modulates the response.
ModerateCaution
Phenytoin depletes folate levels through increased catabolism and impaired absorption, potentially causing megaloblastic anemia. However, folate supplementation may reduce phenytoin levels by enhancing its metabolism, creating a bidirectional interaction that requires careful monitoring.
Recommendation: Folate supplementation (0.5-1mg/day) is generally recommended for patients on phenytoin, but phenytoin levels should be monitored when starting folate. Dose adjustments of phenytoin may be necessary.
ModerateSynergy
Carbamazepine depletes folate through enzyme induction effects on folate metabolism. Folate deficiency during carbamazepine therapy can cause megaloblastic anemia and is particularly concerning in women of childbearing age due to increased neural tube defect risk during pregnancy.
Recommendation: Supplement with folic acid (1mg/day) during carbamazepine therapy, particularly for women of childbearing age. Higher doses (4mg/day) are recommended periconceptionally for women on antiepileptic drugs.
ModerateSynergy
Folic acid supplementation is standard of care during methotrexate therapy. Methotrexate is a folate antagonist that depletes intracellular folate, causing side effects including mucositis, nausea, and cytopenias. Folate supplementation significantly reduces these adverse effects without compromising methotrexate efficacy for rheumatologic conditions.
Recommendation: Take folic acid 1mg daily (or folinic acid 5mg weekly, 24 hours after MTX dose) during methotrexate therapy. This is guideline-recommended and reduces GI, hepatic, and hematologic toxicity. Discuss timing with your rheumatologist.
ModerateCaution
Lamotrigine is a weak inhibitor of dihydrofolate reductase, though clinical studies show minimal effect on serum or RBC folate in most patients. However, folic acid supplementation may theoretically reduce lamotrigine's anticonvulsant efficacy by counteracting its antifolate mechanism. Paradoxically, animal studies suggest the combination of lamotrigine and folic acid may enhance antidepressant effects and seizure threshold. The clinical significance remains debated.
Recommendation: If folate supplementation is needed (particularly in women of childbearing age), use it under prescriber supervision while on lamotrigine. Monitor seizure frequency when starting or changing folate supplementation. Methylfolate may be preferable to folic acid as it bypasses the dihydrofolate reductase step. Do not discontinue lamotrigine or folate without medical guidance.